{"id":143010,"date":"2023-02-28T04:42:00","date_gmt":"2023-02-28T09:42:00","guid":{"rendered":"https:\/\/44.250.171.167\/?p=143010"},"modified":"2023-02-28T08:52:30","modified_gmt":"2023-02-28T13:52:30","slug":"earnings-summary-of-jubilant-ingrevia-limited-for-q3-fy23","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/earnings-summary-of-jubilant-ingrevia-limited-for-q3-fy23\/","title":{"rendered":"Earnings Summary Of Jubilant Ingrevia Limited For Q3 FY23"},"content":{"rendered":"<p>Jubilant Ingrevia Limited (NSE: <span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;JUBLINGREA&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:12925,&quot;3&quot;:{&quot;1&quot;:0},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;9&quot;:1,&quot;12&quot;:0,&quot;15&quot;:&quot;Arial&quot;,&quot;16&quot;:9}\">JUBLINGREA) <\/span>is an integrated pharmaceutical and life sciences company headquartered in Noida, India. The company operates in the specialty chemicals, life sciences, and pharma segments. Jubilant Ingrevia has manufacturing facilities in India and North America and a global sales network covering over 100 countries. The company&#8217;s customers include major pharmaceutical, agrochemical, and other industrial companies worldwide.<\/p>\n<p>For the quarter ended December 31, 2022, Jubilant Ingrevia reported a consolidated revenue of \u20b91,152.63 crore, down 10% YoY. The company&#8217;s Net profit for the quarter stood at \u20b991.53 crore, down 29% YoY, while its Earnings per share for the quarter was \u20b95.75.<\/p>\n<p>The Specialty Chemicals segment increased 14% year on year, while the Nutrition &amp; Health Solutions and Chemical intermediates segments grew by 5% and -25%, respectively.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Jubilant Ingrevia Limited (NSE: JUBLINGREA) is an integrated pharmaceutical and life sciences company headquartered in Noida, India. The company operates in the specialty chemicals, life sciences, and pharma segments. Jubilant Ingrevia has manufacturing facilities in India and North America and a global sales network covering over 100 countries. The company&#8217;s customers include major pharmaceutical, agrochemical, [&hellip;]<\/p>\n","protected":false},"author":1917,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392],"tags":[1115],"class_list":["post-143010","post","type-post","status-publish","format-standard","hentry","category-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":143040,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-jubilant-pharmova-limited-for-q3-fy23\/","url_meta":{"origin":143010,"position":0},"title":"Earnings Summary Of Jubilant Pharmova Limited For Q3 FY23","author":"Hardik Bhandare","date":"February 28, 2023","format":false,"excerpt":"Jubilant Pharmova Limited (NSE: JUBLPHARMA) was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in November 2020. The company was founded in 1978 and is headquartered in Noida, India. It has a presence in over 100 countries worldwide and operates through several subsidiaries\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":146289,"url":"https:\/\/alphastreet.com\/india\/jubilant-ingrevia-q4fy23-earnings-story\/","url_meta":{"origin":143010,"position":1},"title":"Jubilant Ingrevia Q4FY23 Earnings Story","author":"Karan_Singh","date":"May 16, 2023","format":false,"excerpt":"Jubilant Ingrevia is a provider of integrated global life science products and innovative solutions. We cater to customers in the pharmaceutical, nutrition, agrochemical, consumer, and industrial sectors with specialised products and services that are creative, practical, and up to the highest standards of quality. Additionally, Jubilant Ingrevia offers specialised bespoke\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/iStock-585522866.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/iStock-585522866.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/iStock-585522866.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":140011,"url":"https:\/\/alphastreet.com\/india\/jubilant-pharmova-limited-q3-fy23-revenue-increased-by-18\/","url_meta":{"origin":143010,"position":2},"title":"Jubilant Pharmova Limited Q3 FY23; Revenue Increased By 18%","author":"Hardik Bhandare","date":"February 3, 2023","format":false,"excerpt":"Jubilant Pharmova Limited (NSE: JUBLPHARMA) reported a Revenue from Operations of \u20b91,533.22 Crores, a boost of 18% growth from the previous year. The Net Loss for the business is \u20b916.04 Crore from the profit of \u20b950.80 Crore year on year. Earnings per Share is -\u20b90.98 for this quarter.","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/1b64d801-cd27-48d3-b10b-07257f0871c5-scaled.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/1b64d801-cd27-48d3-b10b-07257f0871c5-scaled.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/1b64d801-cd27-48d3-b10b-07257f0871c5-scaled.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/1b64d801-cd27-48d3-b10b-07257f0871c5-scaled.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/1b64d801-cd27-48d3-b10b-07257f0871c5-scaled.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/1b64d801-cd27-48d3-b10b-07257f0871c5-scaled.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":156180,"url":"https:\/\/alphastreet.com\/india\/jubilant-ingrevia-ltd-q2fy24-32-fall-in-profits\/","url_meta":{"origin":143010,"position":3},"title":"Jubilant Ingrevia Ltd Q2FY24; 32% fall in Profits","author":"Hardik Bhandare","date":"November 14, 2023","format":false,"excerpt":"Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards. Financial Results: Jubilant Ingrevia Ltd reported Revenues for Q2FY24 of \u20b91,020.00 Crores down from\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-174.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-174.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-174.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-174.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-174.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-174.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":158702,"url":"https:\/\/alphastreet.com\/india\/jubilant-ingrevia-ltd-q3fy24-58-fall-in-profits\/","url_meta":{"origin":143010,"position":4},"title":"Jubilant Ingrevia Ltd Q3FY24; 58% fall in Profits","author":"Divyansh_Kasana","date":"February 13, 2024","format":false,"excerpt":"Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards. Financial Results: Jubilant Ingrevia Ltd reported Revenues for Q3FY24 of \u20b9966.00 Crores down from\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/02\/image-104.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/02\/image-104.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/02\/image-104.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/02\/image-104.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/02\/image-104.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/02\/image-104.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":139772,"url":"https:\/\/alphastreet.com\/india\/jubilant-foodworks-limited-q3-fy23-net-profit-slides-by-40\/","url_meta":{"origin":143010,"position":5},"title":"Jubilant Foodworks Limited Q3 FY23; Net Profit Slides By 40%","author":"Hardik Bhandare","date":"February 1, 2023","format":false,"excerpt":"Jubilant Foodworks Limited (NSE: JUBLFOOD) reported an increased of 10% in Revenue year over year, to \u20b91,331.81 Crore from \u20b91,210.77 Crore. The Consolidated PAT slides 40% to \u20b980.36 Crore from \u20b9133.19 Crore year on year. Earnings per share is \u20b91.22 for this quarter.","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/dd4c48ae-c921-4ab0-9b95-0849cf6ed0ba-scaled.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/dd4c48ae-c921-4ab0-9b95-0849cf6ed0ba-scaled.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/dd4c48ae-c921-4ab0-9b95-0849cf6ed0ba-scaled.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/dd4c48ae-c921-4ab0-9b95-0849cf6ed0ba-scaled.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/dd4c48ae-c921-4ab0-9b95-0849cf6ed0ba-scaled.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/dd4c48ae-c921-4ab0-9b95-0849cf6ed0ba-scaled.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/143010","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1917"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=143010"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/143010\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=143010"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=143010"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=143010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}